NFL LONG Prospective Study
Key facts
- Who runs it
- University of North Carolina, Chapel Hill
- Where
- Chapel Hill, Milwaukee, and Waltham, United StatesSee the 3 sites
- Trial code
- Status
- Active, not recruiting
- Phase
- Phase 1
- People taking part
- 250 people, planned
- Started
- 12 Mar 2020
- Expected to end
- Aug 2028
- Type of study
- Interventional, 10 groups
- Treatments tested
- [11C] PiB
- [18F] PBR111
- [18F] Flortaucipir
- Record updated
- 22 April 2026
Who can take part
- Age
- 50 years to 70 years
- Sex
- Men only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- At least 1 year of participation in National Football League (NFL groups)
- Retired from professional football
- Ages between 50-70
- No prior exposure to football, collision sports, or prior concussions
- They will be matched to former NFL players by age and estimated premorbid intellectual functioning
- Ages between 50-70
Who cannot take part
- History of Moderate or Severe TBI
- Current primary Axis I diagnosis of Psychotic Disorder
- History or clinical suspicion of other conditions (e.g., epilepsy, stroke, dementia) known to cause cognitive dysfunction
- Diagnosis /associated treatment that would preclude participation in full study protocol (e.g., terminal cancer)
- Any contraindications to MRI, PET, or biological study procedures
Where in United States
- University of North Carolina at Chapel HillChapel Hill, United States
- Medical College of WisconsinMilwaukee, United States
- Boston Children's HospitalWaltham, United States
About the trial
What the trial wants to find out
The purpose of this 5-year prospective research study is to characterize the association between concussions, sub-concussive exposure, and long-term neurologic health outcomes in former NFL players. To achieve the study aims, the investigators will conduct detailed research visits that include clinical outcome assessments, blood-based biomarkers, advanced magnetic resonance imaging (MRI), positron emission tomography (PET) using investigational tracers and genetic testing. Ultimately, the goal of this study is to translate the findings from this study into clinical, interventional studies for at risk former NFL players.
The 10 groups in the trial
- Low Cognitive Functioning/Low Concussion HistoryOther group
Former NFL players with low cognitive function and low concussion history will be included in this group.
Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir
- High Cognitive Functioning/ High Concussion HistoryOther group
Former NFL players with high cognitive function and high concussion history will be included in this group.
Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir
- Low Cognitive Functioning/High Concussion HistoryOther group
Former NFL players with low cognitive function and high concussion history will be included in this group.
Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir
- High Cognitive Functioning/Low Concussion HistoryOther group
Former NFL players with high cognitive function and low concussion history will be included in this group.
Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir
- Healthy Male ControlsOther group
Healthy male demographically matched controls will be included in this group.
Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir
- Low Cognitive Functioning/Medium Concussion HistoryOther group
Former NFL players with low cognitive function and medium concussion history will be included in this group.
Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir
- Medium Cognitive Functioning/Low Concussion HistoryOther group
Former NFL Players with medium cognitive functioning and low concussion history with be included in this group.
Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir
- Medium Cognitive Functioning/Medium Concussion HistoryOther group
Former NFL Players with medium cognitive functioning and medium concussion history with be included in this group.
Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir
- Medium Cognitive Functioning/High Concussion HistoryOther group
Former NFL Players with medium cognitive functioning and high concussion history with be included in this group.
Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir
- High Cognitive Functioning/Medium Concussion HistoryOther group
Former NFL Players with high cognitive functioning and high concussion history with be included in this group.
Treatment: [11C] PiB, [18F] PBR111, and [18F] Flortaucipir
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Neurologic Function Across the Lifespan: A Prospective, LONGitudinal, and Translational Study for Former National Football League Players
- Record updated
- 22 April 2026